MetrioPharm AG - Research

Scientific Publications

Publications on the therapeutic potential of antioxidant therapeutics and in particular on MetrioPharm’s lead compound MP1032

Immune-Modulating Drug MP1032 with SARS-CoV-2
Antiviral Activity In Vitro: A potential Multi-Target
Approach for Prevention and Early Intervention
Treatment of COVID-19

SARS-CoV-2 and mitochondrial health:
implications of lifestyle and ageing

An overview of the state of scientific research on oxidative stress, inflamm-aging, and therapy of chronic inflammatory diseases

Inflammation, But Not Telomere Length,
Predicts Successful Ageing at Extreme Old Age:
A Longitudinal Study of Semi-supercentenarians

Inflammaging and Oxidative Stress
in Human Diseases: From Molecular
Mechanisms to Novel Treatments

ROS Function in Redox Signaling
and Oxidative Stress

Reactive Oxygen Species in the
Immune System

Oxidative stress in the
pathogenesis of psoriasis

Aging and osteoarthritis. Chronic nonspecific
inflammation as a link between aging and osteoarthritis

Emerging Players at the Intersection of Chondrocyte
Loss of Maturational Arrest, Oxidative Stress,
Senescence and Low-Grade
Inflammation in Osteoarthritis

The Link Between Inflammaging and
Degenerative Joint Diseases

Redox Regulation of Inflammation:
Old Elements, a New Story

Here you will find links to websites operated by third parties. If you use these links, you will leave our website. These links are provided for your convenience and do not constitute an endorsement by MetrioPharm AG of the content of such linked websites. MetrioPharm AG has no control over the content of any linked website and is not responsible for those websites or their content or availability. MetrioPharm AG therefore makes no warranties or representations, express or implied, regarding such linked websites, or the information contained therein.